SERUM FERRITIN IN PATIENTS WITH CANCER - DETERMINATION WITH ANTIBODIES TO HELA-CELL AND SPLEEN FERRITIN
SERUM FERRITIN IN PATIENTS WITH CANCER - DETERMINATION WITH ANTIBODIES TO HELA-CELL AND SPLEEN FERRITIN
复制标题
DOI:
10.1016/0009-8981(80)90173-4
复制
发表时间:
1980-01-01
影响因子:
5
通讯作者:
JACOBS, A
中科院分区:
文献类型:
--
作者:
JONES, BM;WORWOOD, M;JACOBS, A
Some malignant tissues and cell lines contain acidic isoferritins; the assay of such isoferritins in serum may be of value in the diagnosis of malignancy. A radioimmunoassay for acidic ferritin purified from HeLa [human cervical carcinoma] cells is described. Examination of purified heart, kidney, liver and spleen ferritin showed that the assay was highly specific for acidic isoferritins. Ferritin concentrations were measured with antibodies to HeLa cell and spleen ferritin in extracts of normal and tumor tissue. Although the tumors contained more HeLa type ferritin than the corresponding normal tissue the HeLa/spleen type ferritin ratio was low. HeLa-type ferritin concentrations were compared with values obtained with anti-spleen ferritin in < 1000 sera from normal subjects and patients with cancer and leukemia. HeLa-type ferritin was not detected (< 2 .mu.g/l) in most normal sera. Concentrations of up to 53 .mu.g/l were found in sera from patients with malignant disease but the HeLa/spleen type ferritin ratio was always very low. There appears to be little application for antibodies to HeLa cell or heart ferritin in the diagnosis or monitoring of cancer.